The first wave of coronavirus cases in the United States has left some with lingering symptoms.
This includes anemia and fatigue, but it’s not uncommon for people to experience more severe symptoms, such as joint pain or severe nausea.
The last time we saw any signs of this kind of severe symptoms in people who hadn’t been vaccinated, it was around 2010.
Now, researchers are working on a vaccine that may work even better than the vaccine that was initially developed in the 1970s.
“What we’re trying to do is to create a vaccine to be able to stop the development of new strains of virus,” said researcher Jonathan Hsu, an associate professor at the University of Pennsylvania and an author of the new study.
The study, which was published in the journal Science Advances, is the first to look at how the early coronaviruses affected the brains of people with mild-to-moderate symptoms.
They found that the early virus caused cells in the brain to begin to form abnormal connections, leading to the formation of abnormal synapses and a decrease in the amount of blood that was circulating.
They also found that people with moderate symptoms experienced a slight decrease in blood flow, which is often the first sign of inflammation.
Hsu’s team hopes that their new vaccine will also block the formation and release of more toxic proteins in the bloodstream that cause the immune system to attack the brain.
But for now, the researchers are focused on trying to prevent new coronaviral strains from being introduced into the human population.
“It’s a challenge, but the way we’re looking at it, there’s no good way to prevent these infections from happening,” Hsu told Polygon.
“The way we can prevent them is to make vaccines that are effective.”
The researchers are currently developing the vaccine, which they say should be ready for testing in the next few months.
Hsi told Polygons he hopes the vaccine will be available to the general public within the next five to 10 years.